Earlier Disclosed In Filing: Abbott Names Robert E. Funck, Jr. As Executive Vice President, Finance, Effective September 1, 2023; Philip P. Boudreau Appointed Senior Vice President, Finance And CFO - Filing
Portfolio Pulse from Benzinga Newsdesk
Abbott Laboratories (ABT) has announced new appointments in its finance department, effective September 1, 2023. Robert E. Funck, Jr. will become Executive Vice President, Finance, while Philip P. Boudreau will be Senior Vice President, Finance and CFO, reporting to Funck. John A. McCoy, Jr. has been appointed Vice President, Controller.
June 12, 2023 | 8:26 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Abbott Laboratories has made new appointments in its finance department, which may lead to changes in the company's financial strategy and performance.
The new appointments in Abbott Laboratories' finance department may lead to changes in the company's financial strategy and performance. However, it is uncertain how these changes will affect the stock price in the short term. The news is relevant and important for investors, but the impact on the stock price is neutral at this time.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100